17 May 2023
EuroPCR 2023 Hotlines/Late-Breaking Trials: mitral and tricuspid valves disease
Session comprising selected EuroPCR 2023 Late-Breaking Trial submissions
Anchorperson:
F. Praz
Spokesperson:
N. Karam
Summary
The presenters share their views on a range of essays and studies. Join them for an update on: Early experience with a d-shape, monoleaflet TMVR system; Outcomes of Mitral Valve-in-Valve, Mitral Valve-in-Ring and Valve-in-Mitral Annular; Calcification: prospective MITRAL; DRAGONFLY-DMR: transcatheter repair by DragonFly device in mitral regurgitation; Outcomes of TMVR vs. medical therapy for secondary mitral regurgitation; HighLife transseptal mitral valve replacement: first-in-man primary end-point outcomes; TRILUMINATE Pivotal: randomised trial of TEER for tricuspid regurgitation; Real-world outcomes for TEER: 30-day results from the TriClip bRIGHT study.
